A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures

Epilepsia

Volumn 41, Issue 9, 2000, Pages 1167-1178

  Aldenkamp, A P ^a   Baker, G ^b   Mulder, O G ^c   Chadwick, D ^b   Cooper, P ^d   Doelman, J ^a   Duncan, R ^e   Gassmann Mayer, C ^f   De Haan, G J ^c   Hughson, C ^f   Hulsman, J ^a   Overweg, J ^c   Pledger, G ^f   Rentmeester, T W ^a   Riaz, H ^d   Wroe, S ^f  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b WALTON HOSPITAL   (United Kingdom)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^d HOPE HOSPITAL   (United Kingdom)

^e SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^f JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adverse effects; Cognitive function; Tapiramate

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT TERM MEMORY; TREATMENT OUTCOME; TREATMENT PLANNING; VERBAL MEMORY;

EID: 0033816145     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00322.x     Document Type: Article

References (28)

1. Topiramate: Preclinical evaluation of a structurally novel anticonvulsant
2. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: Retrospective survey of open-label treatment
3. Topiramate monotherapy for partial onset seizures
4. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
5. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
6. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
7. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400, and 600-mg daily dosages
8. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800, and 1000-mg daily dosages
9. Comparative cognitive effects of anticonvulsants
10. Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research
11. Withdrawal of antiepileptic medication: Effects on cognitive function in children. The results of the multicentre 'Holmfrid' study
12. Cognitive and electrophysiological effects of vigabatrin and carbamazepine
13. Memory and psychomotor effects of oxcarbazepine in healthy normal volunteers
14. Cognitive effects of lamotrigine as first line add-on in patients with localized related (partial) epilepsy
15. Gabapentin and cognition: A double blind, dose-ranging, placebo controlled study in refractory epilepsy
16. The beneficial effect of slowing the initial titration rate of topiramate
17. Onset of anticonvulsant effect of topiramate, a new antiepileptic drug (AED)
18. Cognitive side-effects of antiepileptic drugs: Fact or fiction?
19. Computerized neuropsychological assessment in children with epilepsy
20. Computerized psychological testing in epilepsy
21. Validity of computerized testing: Patient dysfunction and complaints versus measured changes
22. The Neurotoxicity Scale: The validity of a patient-based scale assessing neurotoxicity
23. The Neurotoxicity Scale-II: Results of a patient-based scale assessing neurotoxicity in patients with epilepsy
24. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
25. Assessing cognitive effects of a new AED without the bias of practice effects
26. Topiramate: Clinical profile in epilepsy